Stonepine Capital Management as of Sept. 30, 2019
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 26 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation | 18.2 | $19M | 1.2M | 15.16 | |
| Oxford Immunotec Global | 11.0 | $11M | 682k | 16.63 | |
| BioDelivery Sciences International | 10.6 | $11M | 2.6M | 4.21 | |
| Enanta Pharmaceuticals (ENTA) | 7.6 | $7.8M | 130k | 60.08 | |
| Neos Therapeutics | 6.5 | $6.7M | 4.5M | 1.48 | |
| Cumberland Pharmaceuticals (CPIX) | 5.0 | $5.1M | 860k | 5.93 | |
| Apollo Endosurgery | 4.7 | $4.8M | 1.5M | 3.29 | |
| Opiant Pharmaceuticals | 4.6 | $4.7M | 314k | 15.05 | |
| Xoma Corp Del (XOMA) | 4.4 | $4.5M | 230k | 19.71 | |
| Iveric Bio | 4.2 | $4.3M | 3.8M | 1.12 | |
| Adamas Pharmaceuticals | 3.7 | $3.8M | 751k | 5.11 | |
| Htg Molecular Diagnostics | 3.7 | $3.8M | 5.8M | 0.66 | |
| Cti Biopharma | 3.0 | $3.1M | 3.7M | 0.84 | |
| Ligand Pharmaceuticals In (LGND) | 2.9 | $3.0M | 30k | 99.55 | |
| Noveliontherapeuti.. | 2.6 | $2.7M | 3.7M | 0.73 | |
| Aptevo Therapeutics Inc apvo | 1.9 | $2.0M | 3.4M | 0.59 | |
| Alimera Sciences | 1.5 | $1.6M | 2.7M | 0.57 | |
| Correvio Pharma Corp | 1.0 | $1.0M | 509k | 2.00 | |
| Interpace Diagnostics | 0.9 | $917k | 1.2M | 0.79 | |
| Chiasma | 0.5 | $543k | 110k | 4.95 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $383k | 33k | 11.59 | |
| Acer Therapeutics | 0.3 | $364k | 114k | 3.19 | |
| Retrophin | 0.3 | $344k | 30k | 11.59 | |
| Affimed Therapeutics B V | 0.2 | $231k | 79k | 2.94 | |
| DURECT Corporation | 0.2 | $184k | 100k | 1.84 | |
| Diamedica Therapeutics (DMAC) | 0.0 | $28k | 14k | 2.04 |
